Stenocare A/S (CPH:STENO)

Market Cap	61.34M +597.7%
Revenue (ttm)	7.02M +184.0%
Net Income	-2.39M
EPS	-0.06
Shares Out	43.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167,246
Average Volume	114,230
Open	1.420
Previous Close	1.420
Day's Range	1.305 - 1.440
52-Week Range	0.194 - 2.800
Beta	0.29
RSI	47.23
Earnings Date	Feb 27, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 8
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: STENO

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.54% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.